Zobrazeno 1 - 10
of 94
pro vyhledávání: '"S, Sörenson"'
Autor:
Trond Eirik Strand, Stein Sundstrøm, Nils Wilking, C. Von Plessen, S. Sörenson, Ernst Omenaas, Tore Wentzel-Larsen
Publikováno v:
Thorax. 63:866-871
Background: Chemotherapy is the primary treatment option for patients with advanced non-small cell lung cancer (ANSCLC). We investigated whether the introduction of modern third-generation chemotherapy was associated with survival benefits in a natio
Publikováno v:
Acta Oncologica. 30:947-957
The Sickness Impact Profile (SIP) and the Hospital Anxiety and Depression scale (HAD) were used for assessment of physical and psychosocial functioning and emotional distress in patients with small cell lung cancer (SCLC) receiving chemotherapy. Trea
Autor:
S, Sörenson
Publikováno v:
Lakartidningen. 94(16)
Publikováno v:
Allergy. 48(6)
The effect of immunotherapy (IT) on T-cell subsets in peripheral blood and bronchoalveolar lavage fluid (BAL) was examined in 15 patients with rhinoconjunctivitis and asthma caused by sensitivity to birch pollen. They were treated with IT for 3 years
Publikováno v:
Acta oncologica (Stockholm, Sweden). 31(1)
Sixty-two patients with small cell lung cancer, 36-80 years of age, who were receiving chemotherapy during a maximum of one year, were consecutively included in a study of quality of life during treatment. An interim version (C-36) of the EORTC Core
Publikováno v:
European Journal of Cancer Supplements. 7:513
Publikováno v:
Lakartidningen. 87(16)
Autor:
Bengt Bergman, S Sörenson
Publikováno v:
Acta oncologica (Stockholm, Sweden). 29(8)
Ninety patients with small cell lung cancer, who received combination chemotherapy, were studied with regard to hospitalization during the treatment period. Chemotherapy was discontinued in case of tumour progression, or, if progression did not occur
Autor:
S. Sörenson
Publikováno v:
Respiratory Medicine. 92:1373
Autor:
B, Bergman, S, Sörenson
Publikováno v:
European journal of respiratory diseases. 70(1)
Forty-four patients with small cell lung cancer (SCLC), who were working in some kind of profession when they were taken ill, were studied with regard to return to work during or after cancer treatment. All patients received combination chemotherapy